Trial Profile
A study of RXI-762 for the treatment of cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2019
Price :
$35
*
At a glance
- Drugs RXI-762 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 12 Aug 2019 According to a Phio Pharmaceuticals media release, the company expects to start clinical studies of PH-762 in 2020.
- 14 Aug 2017 New trial record
- 08 Aug 2017 According to RXi Pharmaceuticals media release, the company plans clinical development of RXI-762 in 2018.